Skip to main content
Insights into Imaging
Fig. 5 | Insights into Imaging

Fig. 5

From: Single-centre survival analysis over 10 years after MR-guided radiofrequency ablation of liver metastases from different tumour entities

Fig. 5

Kaplan–Meier curve shows superior hepatic PFS in 72 CRC patients for surgical treatment in combination with CTX, compared to surgery alone (a median 14.4 and 6.6 months, SD 5.1, 1.4; 95% CI 4.4–24.5 and 3.8–9.4). Hepatic PFS was significantly higher for RFA treated liver lesions up to 29 mm compared to larger lesions (b, c median 19.0 months vs. 7.8 months; SD 2.7 and 3.3, 95% CI 13.7–24.4 and 1.2–14.4; p = 0.035). Extrahepatic PFS in CRC patients revealed no significant differences according to either the performed therapy before RFA (d p = 0.580) or the lesion size of the RFA-treated metastases (e, f p = 0.067)

Back to article page